Ropinirole Hydrochloride

DRUG3 trials

Sponsors

Agarwal, Pinky, M.D., Roxane Laboratories

Conditions

Parkinson's DiseaseRestless Leg Syndrome

Phase 3

Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease

Agarwal, Pinky, M.D.Parkinson's Disease

Start: 2005-11-30Target: 20Updated: 2006-02-03

Unknown Phase

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions

CompletedNCT00673088

Roxane LaboratoriesParkinson's Disease, Restless Leg Syndrome

Start: 2004-02-29End: 2004-02-29Updated: 2018-01-23

A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions

CompletedNCT00674310

Roxane LaboratoriesParkinson's Disease, Restless Leg Syndrome

Start: 2004-02-29End: 2004-02-29Updated: 2018-01-23